MetS is also called “insulin resistance syndrome.” Reduced insulin sensitivity increases the risk of diabetes, abdominal obesity [6], dyslipidemia [6], hypertension [7], and cardiovascular diseases [8]. Here, INS is linked to metabolic syndrome.